Search stocks

Find any stock by ticker or company name

Home

CAMP

Camp4 Therapeutics Corporation (CAMP)

NGM – Real vaqt narxi. Valyuta: USD

4.45

+0.28 (6.71%)

Bozor ochiq: Aug 12, 2026, 11:57 AM EDT

4.44

+0.27 (6.47%)

Oldingi bozordan keyin: Aug 11, 2026, 5:50 PM EDT

Umumiy
Yangiliklar
Grafik
Hisobotlar
Dividendlar
Kutilma
Egalik
Profil

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz haqimizda

Biz bilan bog'lanish

[email protected]

Bizni kuzating

Instagram
Telegram
LinkedIn

Barcha huquqlar himoyalangan.

Foydalanish shartlari

Bosh sahifa
Kuzatuv
Bozorlar
Kalendar
Skriner
Yangiliklar
Biz haqimizda

CAMP - Camp4 Therapeutics Corporation... | Finranks

Home

CAMP

Camp4 Therapeutics Corporation (CAMP)

NGM – Real vaqt narxi. Valyuta: USD

4.45

+0.28 (6.71%)

Bozor ochiq: Aug 12, 2026, 11:57 AM EDT

4.44

+0.27 (6.47%)

Oldingi bozordan keyin: Aug 11, 2026, 5:50 PM EDT

Umumiy
Yangiliklar
Grafik
Hisobotlar
Dividendlar
Kutilma
Egalik
Profil

06.08.2026

CAMP4 advances rare disease treatment for SYNGAP1 into human trials

CAMP4 Therapeutics received regulatory clearance in Australia and Argentina to begin a Phase 1/2 trial of CMP-002, its experimental ASO therapy for SYNGAP1-related disorders. The trial will enroll at least 30 children ages 2 to 18 and use a double-blind, placebo-controlled design, with placebo recipients able to transition to the treatment if early results are positive.

04.08.2026

CAMP4 Therapeutics Announces Second Closing of $100 Million Private Placement

Proceeds of $50.1 million will be used to support the Company's advancement of CMP-002 for the treatment of SYNGAP1-related disorder Proceeds of $50.1 million will be used to support the Company's advancement of CMP-002 for the treatment of SYNGAP1-related disorder

Videolar

No Data

There is no data to display

Press-relizlar

04.08.2026